Logo

T2 Biosystems

T2 Biosystems Receives Nasdaq Delisting Notice

In October, the company regained compliance with the Nasdaq minimum bid price requirement after undergoing a reverse stock split. 

In Brief This Week: Thermo Fisher, Myriad Genetics, T2 Biosystems, DermTech, More

News items for the week of Oct. 30, 2023

T2 Biosystems Gets FDA 510(k) Clearance for Biothreat Panel

The clearance allows the firm to immediately begin marketing an assay that simultaneously detects six biothreat pathogens directly from blood.

Earnings Roundup: T2 Biosystems, Personalis, Standard BioTools, Biodesix, MyHealthChecked

These genomics and diagnostics firms posted their quarterly financial results this week.

In Brief This Week: DermTech, Waters, ERS Genomics, Transomic, Karius, T2 Biosystems, More

News items for the week of July 31, 2023

Jul 21, 2023

In Brief This Week: Scripps Research Translational Institute, DermTech, T2 Biosystems, Bio-Rad, More

Jul 14, 2023

In Brief This Week: DermTech, T2 Biosystems, Cofactor Genomics, Bio-Techne, Lunaphore, More

Jun 30, 2023

In Brief This Week: PacBio, AACR, Devyser, T2 Biosystems, AgriPlex Genomics, MolGen, VolitionRx

Jun 9, 2023

T2 Biosystems, Vanderbilt University Medical Center Partner on Prospective Bacterial Sepsis Dx Study

May 23, 2023

T2 Biosystems Lays off 30 Percent of Workforce as Q1 Revenues Drop 71 Percent

Mar 30, 2023

Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium

Mar 16, 2023

In Brief This Week: PerkinElmer, Bruker, Calibre Scientific, Prenetics, T2 Biosystems, More

Mar 3, 2023

T2 Biosystems Readies Biothreat Panel for FDA Submission While Keeping Eye on Sepsis Market
Premium

Feb 15, 2023

T2 Biosystems Prices $12M Public Offering

Jan 27, 2023

In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More

Nov 11, 2022

Earnings Roundup: HTG Molecular, T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen

Nov 7, 2022

HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects

Nov 1, 2022

T2 Biosystems Regains Compliance with Nasdaq Listing Requirement

Oct 14, 2022

Canaccord Downgrades T2 Biosystems to Hold

Oct 12, 2022

T2 Biosystems Effects Reverse Stock Split, Reports 50 Percent Drop in Preliminary Q3 Revenues

Sep 29, 2022

BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option

Sep 23, 2022

In Brief This Week: Thermo Fisher Scientific, Exact Sciences, T2 Biosystems, Helix, More

Aug 30, 2022

T2 Biosystems Regains Nasdaq Listing Requirements

Aug 16, 2022

Earnings Roundup: Lucira Health, T2 Biosystems, Interpace Biosciences

Jul 15, 2022

In Brief This Week: Centogene, Novacyt, T2 Biosystems, Inotiv, Oxford Nanopore, More